Do you want to link to this Amgen website and leave Amgen.com.hk?

YOU ARE NOW LEAVING THIS WEBSITE.

Amgen Hong Kong takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.

RESPONSIBILITY

Making a positive difference in the world is at the heart of what we do at Amgen - and it goes beyond making vital medicines. Each year, Amgen and our staff members dedicate significant resources towards building a better tomorrow.

Amgen’s Commitment to Corporate Social Responsibility

Making a positive impact on the world is at the heart of all we do at Amgen. Amgen uses science and innovation to dramatically improve people’s lives, and our mission to serve patients attracts a workforce committed to making a difference for others. Making that positive difference is ingrained in Amgen’s business and culture, and includes our philanthropic efforts, our commitments to give back to the communities in which we live and work, and our environmental sustainability initiatives. Through the Amgen Foundation, we’re inspiring the next generation of innovators by advancing science education programming globally. In addition, Amgen staff members devote tens of thousands of volunteer hours to support local community activities throughout the world. Amgen is also committed to environmentally responsible operations, which includes using natural resources wisely and considering our overall impact on the environment.

HK-08415-AMGEN-2022-Jun
Date of Approval: Jun 2022

In This Section

Research and Development Strategy

Amgen has built an organization distinguished by world-class scientists with a talent for applying novel approaches to treat disease. Our R&D strategy aims to align and engage our talent, prioritize investments, and seize scientific opportunities.

abe1abe1

Amgen Biotech Experience and Scholar Program

We aim to share and impart scientific knowledge to the community to advance healthcare and health literacy.

Pipeline

Amgen has created a robust and differentiated pipeline, leveraging state-of-the-art science to create medicines for serious illnesses.